Collin Britten - Publications
Affiliations: | 2016- | Chemical, Biological and Materials Engineering | University of Oklahoma, Norman, OK, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2021 | Frickenstein AN, Hagood JM, Britten CN, Abbott BS, McNally MW, Vopat CA, Patterson EG, MacCuaig WM, Jain A, Walters KB, McNally LR. Mesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect. Pharmaceutics. 13. PMID 33920503 DOI: 10.3390/pharmaceutics13040570 | 0.345 | |||
2020 | Mohan V, Naske CD, Britten CN, Karimi L, Walters KB. Hydroxide-catalyzed cleavage of selective ester bonds in phosphatidylcholine: An FTIR study Vibrational Spectroscopy. 109: 103055. DOI: 10.1016/J.Vibspec.2020.103055 | 0.556 | |||
2020 | Wynne A, Frisch JR, Britten C, Walters KB. Synthesis, characterization, and stability of poly(ethylene-co-acrylic acid) films surface functionalized with fluorescent moieties Reactive and Functional Polymers. 152: 104598. DOI: 10.1016/J.Reactfunctpolym.2020.104598 | 0.558 | |||
2011 | Fox BA, Schendel DJ, Butterfield LH, Aamdal S, Allison JP, Ascierto PA, Atkins MB, Bartunkova J, Bergmann L, Berinstein N, Bonorino CC, Borden E, Bramson JL, Britten CM, Cao X, et al. Defining the critical hurdles in cancer immunotherapy. Journal of Translational Medicine. 9: 214. PMID 22168571 DOI: 10.1186/1479-5876-9-214 | 0.302 | |||
2008 | Britten CM. [Concepts for clinical testing of biological agents exemplified for vaccines]. Onkologie. 31: 58-63. PMID 18487871 DOI: 10.1159/000113033 | 0.316 | |||
Show low-probability matches. |